3 completed, 1 terminated, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Clioquinol: new trials by email Literature Review of Clioquinol trials Research Report on Clioquinol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study Clioquinol - Epilepsy Intractable | Phase 2 | Completed | KU Leuven | 10 | 2022-03-01 | 2026-10-20 |
| Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp Allantoin/ Coal Tar/ Clioquinol, Allantoin/ Coal Tar/ Clioquinol/ Triclosan - Seborrheic Dermatitis, Psoriasis of Scalp | Completed | Laboratorios Silanes S.A. de C.V. | 90 | 2021-11-29 | 2022-04-13 | |
| Magen Haim Project - Assessing Hand Hygiene Formulas AniosGel 85 NPC, Softa-Man (Braun), Septol - Comparing Use of Hand Hygiene Products | Phase 4 | Unknown | Sheba Medical Center | 1505 | 2017-06-15 | 2017-10-17 |
| Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous polymyxin B sulphate + prednisolone + benzocaine + clioquinol, betamethasone + gentamicin + tolnaftato + cleoquinol - Eczema | Phase 3 | Completed | EMS | 76 | 2012-05-01 | 2021-02-24 |
| Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy Clioquinol - Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 1 | Terminated | University Health Network, Toronto | 11 | 2009-08-01 | 2015-06-22 |
Anemia, Refractory, with Excess of Blasts (1) · Dermatitis (1) · Dermatitis, Atopic (1) · Dermatitis, Seborrheic (1) · Drug Resistant Epilepsy (1) · Eczema (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
EMS (1) · KU Leuven (1) · Laboratorios Silanes S.A. de C.V. (1) · Sheba Medical Center (1) · University Health Network, Toronto (1)
Belgium (1) · Canada (1) · Israel (1) · Mexico (1)
Dror Harats, Prof. (1) · Lieven Lagae, MD PhD (1) · Mark Minden, MD (1)